CD4 and hematocrit: We observed that HAIC therapy induced significant increases in the fractions of CD8+ T subsets (C03_CD8T_DTHD1: p = 0.015; C04_CD8T_SLC4A10: p = 0.038), naïve CD4+ T cells (C05_CD4T_ADAM23: p = 0.005), TFH cells (C12_CD4T_FKBP5: p = 0.038), and T helper cells (C06_CD4T_IL7R, C08_CD4T_PTPN13: p < 0.001) in the HT samples (Figure 2F).